Neena Pursnani, MD
Family Medicine · Windsor, CTNPI 1306871355
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $646 and has fallen 58.0% since, to $271 in 2025.
Across 140 payments — averaging $21.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$678
- Lilly USA, LLC$401
- Novo Nordisk$236
- Pfizer$209
- AstraZeneca$183
- Biohaven Pharmaceuticals, Inc.$149
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,978100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 29 | $678 |
| Lilly USA, LLC | 20 | $401 |
| Novo Nordisk | 12 | $236 |
| Pfizer | 10 | $209 |
| AstraZeneca | 11 | $183 |
| Biohaven Pharmaceuticals, Inc. | 2 | $149 |
| Boehringer Ingelheim | 6 | $128 |
| Exact Sciences | 5 | $109 |
| GSK | 5 | $105 |
| Astellas Pharma US Inc | 4 | $83 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $69 |
| Amarin Pharma, Inc. | 4 | $67 |
| Actelion Pharmaceuticals US, Inc. | 2 | $65 |
| Ultragenyx Pharmaceutical Inc. | 3 | $61 |
| Sanofi-aventis U.S. LLC | 3 | $49 |
| Merck | 3 | $49 |
| Esperion Therapeutics, Inc. | 2 | $46 |
| Eisai Inc. | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Amgen | 1 | $24 |
| Abbott | 1 | $23 |
| Ironshore Pharmaceuticals Inc. | 1 | $22 |
| Mylan Specialty L.p. | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| Adlon Therapeutics L.p. | 1 | $20 |
| Medtronic | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $15 |
How this compares
$2,978 in reported general payments places this provider in the 80th percentile of 588 family medicine providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SynthroidLevothyroxine Sodium | 13 | $1,808 |
| Omeprazole | 18 | $474 |
| Levothyroxine Sodium | 59 | $440 |
| Atorvastatin Calcium | 60 | $435 |
| Lisinopril | 35 | $263 |
| Sertraline Hcl | 29 | $191 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $163 |
| Trazodone Hcl | 20 | $145 |
| Hydrochlorothiazide | 22 | $144 |
| Rosuvastatin Calcium | 26 | $144 |
| Simvastatin | 14 | $133 |
| Metformin Hcl ErMetformin Hcl | 16 | $122 |
| Losartan Potassium | 24 | $121 |
| Amlodipine Besylate | 13 | $92 |
| Escitalopram Oxalate | 17 | $85 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid | $678 | $1,80813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 588 family medicine providers in Connecticut.
Other family medicine in Windsor
- Theodore BrunoDurham$201K
- Kenneth DardickStorrs$146K
- Raymond KurkerSouth Windsor$107K
- Thao DoranMarlborough$102K
- Raja FattalehPutnam$53K
- Nicholas TzikasNew Haven$46K
- Helar CamposNew London$29K
- Kristin GianniniVernon$28K
- Sanjeev RaoBridgeport$27K
- Michael BeyVernon Rockville$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.